CBOE GLOBAL MARKETS INC (CBOE)

US12503M1080 - Common Stock

210.98  +2.48 (+1.19%)

Premarket: 208.5 -2.48 (-1.18%)

Fundamental Rating

6

Overall CBOE gets a fundamental rating of 6 out of 10. We evaluated CBOE against 218 industry peers in the Capital Markets industry. CBOE gets an excellent profitability rating and is at the same time showing great financial health properties. CBOE is quite expensive at the moment. It does show a decent growth rate.



8

1. Profitability

1.1 Basic Checks

In the past year CBOE was profitable.
CBOE had a positive operating cash flow in the past year.
Each year in the past 5 years CBOE has been profitable.
CBOE had a positive operating cash flow in each of the past 5 years.

1.2 Ratios

CBOE has a better Return On Assets (8.27%) than 83.26% of its industry peers.
CBOE has a better Return On Equity (19.04%) than 85.12% of its industry peers.
CBOE has a Return On Invested Capital of 11.87%. This is amongst the best in the industry. CBOE outperforms 87.91% of its industry peers.
CBOE had an Average Return On Invested Capital over the past 3 years of 10.49%. This is above the industry average of 6.96%.
The last Return On Invested Capital (11.87%) for CBOE is above the 3 year average (10.49%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 8.27%
ROE 19.04%
ROIC 11.87%
ROA(3y)7.07%
ROA(5y)7.13%
ROE(3y)13.46%
ROE(5y)13.09%
ROIC(3y)10.49%
ROIC(5y)9.56%

1.3 Margins

Looking at the Profit Margin, with a value of 20.11%, CBOE is in line with its industry, outperforming 56.74% of the companies in the same industry.
CBOE's Profit Margin has improved in the last couple of years.
With a Operating Margin value of 29.94%, CBOE perfoms like the industry average, outperforming 53.02% of the companies in the same industry.
In the last couple of years the Operating Margin of CBOE has grown nicely.
With a Gross Margin value of 52.39%, CBOE perfoms like the industry average, outperforming 53.95% of the companies in the same industry.
CBOE's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 29.94%
PM (TTM) 20.11%
GM 52.39%
OM growth 3Y11%
OM growth 5Y4.43%
PM growth 3Y13.78%
PM growth 5Y5.66%
GM growth 3Y11.57%
GM growth 5Y2.95%

8

2. Health

2.1 Basic Checks

Compared to 1 year ago, CBOE has less shares outstanding
The number of shares outstanding for CBOE has been reduced compared to 5 years ago.
Compared to 1 year ago, CBOE has an improved debt to assets ratio.

2.2 Solvency

CBOE has an Altman-Z score of 3.86. This indicates that CBOE is financially healthy and has little risk of bankruptcy at the moment.
CBOE has a Altman-Z score of 3.86. This is amongst the best in the industry. CBOE outperforms 81.40% of its industry peers.
The Debt to FCF ratio of CBOE is 0.50, which is an excellent value as it means it would take CBOE, only 0.50 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of CBOE (0.50) is better than 89.30% of its industry peers.
CBOE has a Debt/Equity ratio of 0.36. This is a healthy value indicating a solid balance between debt and equity.
CBOE has a better Debt to Equity ratio (0.36) than 75.35% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.36
Debt/FCF 0.5
Altman-Z 3.86
ROIC/WACCN/A
WACCN/A

2.3 Liquidity

CBOE has a Current Ratio of 1.23. This is a normal value and indicates that CBOE is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.23, CBOE is in line with its industry, outperforming 57.21% of the companies in the same industry.
A Quick Ratio of 1.23 indicates that CBOE should not have too much problems paying its short term obligations.
Looking at the Quick ratio, with a value of 1.23, CBOE is in line with its industry, outperforming 57.21% of the companies in the same industry.
The current and quick ratio evaluation for CBOE is rather negative, while it does have excellent solvency and profitability. These ratios do not necessarly indicate liquidity issues and need to be evaluated against the specifics of the business.
Industry RankSector Rank
Current Ratio 1.23
Quick Ratio 1.23

4

3. Growth

3.1 Past

CBOE shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 13.79%, which is quite good.
CBOE shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 9.17% yearly.
CBOE shows a decrease in Revenue. In the last year, the revenue decreased by -4.67%.
CBOE shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 6.39% yearly.
EPS 1Y (TTM)13.79%
EPS 3Y13.89%
EPS 5Y9.17%
EPS Q2Q%7.77%
Revenue 1Y (TTM)-4.67%
Revenue growth 3Y3.26%
Revenue growth 5Y6.39%
Sales Q2Q%10.72%

3.2 Future

CBOE is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 7.54% yearly.
CBOE is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.13% yearly.
EPS Next Y13.35%
EPS Next 2Y9.44%
EPS Next 3Y8.19%
EPS Next 5Y7.54%
Revenue Next Year7.82%
Revenue Next 2Y6.33%
Revenue Next 3Y5.62%
Revenue Next 5Y4.13%

3.3 Evolution

The EPS growth rate is stable: in the next years the growth will be about the same than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.

3

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 24.59 indicates a rather expensive valuation of CBOE.
Based on the Price/Earnings ratio, CBOE is valued a bit more expensive than 63.72% of the companies in the same industry.
CBOE's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 28.96.
A Price/Forward Earnings ratio of 22.58 indicates a rather expensive valuation of CBOE.
Compared to the rest of the industry, the Price/Forward Earnings ratio of CBOE indicates a slightly more expensive valuation: CBOE is more expensive than 63.26% of the companies listed in the same industry.
CBOE is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 23.82, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 24.59
Fwd PE 22.58

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CBOE indicates a somewhat cheap valuation: CBOE is cheaper than 72.09% of the companies listed in the same industry.
CBOE's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. CBOE is cheaper than 76.74% of the companies in the same industry.
Industry RankSector Rank
P/FCF 7.65
EV/EBITDA 17.69

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates CBOE does not grow enough to justify the current Price/Earnings ratio.
The excellent profitability rating of CBOE may justify a higher PE ratio.
PEG (NY)1.84
PEG (5Y)2.68
EPS Next 2Y9.44%
EPS Next 3Y8.19%

5

5. Dividend

5.1 Amount

CBOE has a Yearly Dividend Yield of 1.28%.
CBOE's Dividend Yield is slightly below the industry average, which is at 9.01.
With a Dividend Yield of 1.28, CBOE pays less dividend than the S&P500 average, which is at 2.23.
Industry RankSector Rank
Dividend Yield 1.28%

5.2 History

The dividend of CBOE is nicely growing with an annual growth rate of 12.72%!
CBOE has paid a dividend for at least 10 years, which is a reliable track record.
CBOE has not decreased its dividend for at least 10 years, so it has a reliable track record of non decreasing dividend.
Dividend Growth(5Y)12.72%
Div Incr Years10
Div Non Decr Years10

5.3 Sustainability

CBOE pays out 30.51% of its income as dividend. This is a sustainable payout ratio.
The dividend of CBOE is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP30.51%
EPS Next 2Y9.44%
EPS Next 3Y8.19%

CBOE GLOBAL MARKETS INC

NYSEARCA:CBOE (11/21/2024, 8:17:46 PM)

Premarket: 208.5 -2.48 (-1.18%)

210.98

+2.48 (+1.19%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap22.09B
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield 1.28%
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE 24.59
Fwd PE 22.58
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)1.84
PEG (5Y)2.68
Profitability
Industry RankSector Rank
ROA 8.27%
ROE 19.04%
ROCE
ROIC
ROICexc
ROICexgc
OM 29.94%
PM (TTM) 20.11%
GM 52.39%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.41
Health
Industry RankSector Rank
Debt/Equity 0.36
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 1.23
Quick Ratio 1.23
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)13.79%
EPS 3Y13.89%
EPS 5Y
EPS Q2Q%
EPS Next Y13.35%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-4.67%
Revenue growth 3Y3.26%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y